As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top ...

Pharmaceutical company Moderna (MRNA) and energy provider Enbridge (ENB) are scheduled to release earnings on Friday. The US Census Bureau will report January's retail sales data, expecting a ...

Ward said it would be good to see data from studies of other variant vaccine boosters to compare to the Moderna combination. Expert advisors "must already be thinking about the population at risk ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...

German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent ... while investors focused on data pointing to a cooling U.S. economy. Novavax sees royalties, reduced expenses ...

Moderna is a biotechnology company primarily engaged in the development and manufacturing of messenger RNA (mRNA) medicines and vaccines. It spearheads innovation using mRNA technology to pursue ...

Looking ahead to 2025, Moderna expects revenue of $1.5 to $2.5bn. Credit: Tada Images/Shutterstock. Moderna has reported revenue of $1bn for the fourth quarter (Q4) of 2024 – a sharp decline from the ...